These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 14583958)

  • 21. Interventions for smoking cessation and reduction in individuals with schizophrenia.
    Tsoi DT; Porwal M; Webster AC
    Cochrane Database Syst Rev; 2010 Jun; (6):CD007253. PubMed ID: 20556777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mass media interventions for smoking cessation in adults.
    Bala M; Strzeszynski L; Cahill K
    Cochrane Database Syst Rev; 2008 Jan; (1):CD004704. PubMed ID: 18254058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple risk factor interventions for primary prevention of coronary heart disease.
    Ebrahim S; Davey Smith G
    Cochrane Database Syst Rev; 2000; (2):CD001561. PubMed ID: 10796813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Smoking as a risk factor for Alzheimer's disease: contrasting evidence from a systematic review of case-control and cohort studies.
    Almeida OP; Hulse GK; Lawrence D; Flicker L
    Addiction; 2002 Jan; 97(1):15-28. PubMed ID: 11895267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomised trials.
    Pignone M; Phillips C; Mulrow C
    BMJ; 2000 Oct; 321(7267):983-6. PubMed ID: 11039962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Smoking cessation and risk of myocardial reinfarction in coronary patients: a nested case-control study].
    Serrano M; Madoz E; Ezpeleta I; San Julián B; Amézqueta C; Pérez Marco JA; de Irala J
    Rev Esp Cardiol; 2003 May; 56(5):445-51. PubMed ID: 12737781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of smoking cessation on mortality after myocardial infarction: meta-analysis of cohort studies.
    Wilson K; Gibson N; Willan A; Cook D
    Arch Intern Med; 2000 Apr; 160(7):939-44. PubMed ID: 10761958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. UK heart disease prevention project: incidence and mortality results.
    Rose G; Tunstall-Pedoe HD; Heller RF
    Lancet; 1983 May; 1(8333):1062-6. PubMed ID: 6133103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factor modification through nonpharmacological interventions in patients with coronary heart disease.
    Sebregts EH; Falger PR; Bär FW
    J Psychosom Res; 2000; 48(4-5):425-41. PubMed ID: 10880664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The secondary prevention of coronary artery disease.
    Merz CN; Rozanski A; Forrester JS
    Am J Med; 1997 Jun; 102(6):572-81. PubMed ID: 9217673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomised controlled trial of anti-smoking advice: final (20 year) results.
    Rose G; Colwell L
    J Epidemiol Community Health; 1992 Feb; 46(1):75-7. PubMed ID: 1573365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Belgian Heart Disease Prevention Project: 10-year mortality follow-up.
    De Backer G; Kornitzer M; Dramaix M; Kittel F; Thilly C; Graffar M; Vuylsteek K
    Eur Heart J; 1988 Mar; 9(3):238-42. PubMed ID: 3289930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impacts of health examinations and smoking on disease mortality risk in Japan: a longitudinal cohort of 720,611 Japanese life insured persons.
    Suka M; Sugimori H; Yoshida K
    Environ Health Prev Med; 2002 Sep; 7(4):169-72. PubMed ID: 21432273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent international changes in coronary heart disease mortality.
    Epstein FH
    Nutr Metab; 1980; 24 Suppl 1():45-9. PubMed ID: 7454137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular risk of smoking and benefits of smoking cessation.
    Gallucci G; Tartarone A; Lerose R; Lalinga AV; Capobianco AM
    J Thorac Dis; 2020 Jul; 12(7):3866-3876. PubMed ID: 32802468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of quitting smoking on diabetes-related complications: A scoping review with a systematic search strategy.
    Walicka M; Krysiński A; La Rosa GRM; Sun A; Campagna D; Di Ciaula A; Dugal T; Kengne A; Le Dinh P; Misra A; Polosa R; Raza SA; Russo C; Sammut R; Somasundaram N;
    Diabetes Metab Syndr; 2024 May; 18(5):103044. PubMed ID: 38810420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in smoking behavior and adherence to preventive guidelines among smokers after a heart attack.
    Choi YJ; Park JS; Kim U; Lee SH; Son JW; Shin DG; Kim YJ; Jeong MH; Ahn YK; Cho MC; Bae JW; Kim CJ; Cho JM; Han KR; Lee JH
    J Geriatr Cardiol; 2013 Jun; 10(2):146-50. PubMed ID: 23888174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipid lowering drugs for patients who continue to smoke?
    Isles CG; Norrie J
    Heart; 2000 Jun; 83(6):619-20. PubMed ID: 10814615
    [No Abstract]   [Full Text] [Related]  

  • 39. Development of coronary prevention strategies by health authorities in the United Kingdom.
    Smith WC; Kenicer MB; Davis AM; Evans AE; Graham JM; Yarnell J
    Community Med; 1989 May; 11(2):108-15. PubMed ID: 2752719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The reasons coronary heart disease mortality has increased in China.
    Ge L; Ge J
    Am Heart Hosp J; 2007; 5(2):97-9. PubMed ID: 17478975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.